As evidence, portal inflammatory infiltrates in human NASH patients are characterized by both broad leukocyte subset markers (CD68, CD3, CD8, CD4, CD20, and neutrophil elastase) and selected inflammatory markers (matrix metalloproteinase 9 and interleukin- [IL-] 17) [51]. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.